Year |
Citation |
Score |
2024 |
Hadj Mohamed A, Ricco C, Pinon A, Lagarde N, Goya-Jorge E, Mouhsine H, Msaddek M, Liagre B, Sylla-Iyarreta Veitía M. A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes. Chemmedchem. e202400151. PMID 39135463 DOI: 10.1002/cmdc.202400151 |
0.757 |
|
2023 |
Hadj Mohamed A, Pinon A, Lagarde N, Ricco C, Goya-Jorge E, Mouhsine H, Msaddek M, Liagre B, Veitía MS. Colorectal anticancer activity of a novel class of triazolic triarylmethane derivatives. Rsc Medicinal Chemistry. 15: 660-676. PMID 38389891 DOI: 10.1039/d3md00467h |
0.761 |
|
2022 |
Hadj Mohamed A, Pinon A, Lagarde N, Goya Jorge E, Mouhsine H, Msaddek M, Liagre B, Sylla-Iyarreta Veitía M. Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, and Studies. Biomolecules. 13. PMID 36671439 DOI: 10.3390/biom13010054 |
0.767 |
|
2022 |
Sellami A, Réau M, Montes M, Lagarde N. Review of studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns. Frontiers in Endocrinology. 13: 986016. PMID 36176461 DOI: 10.3389/fendo.2022.986016 |
0.384 |
|
2021 |
Lessigiarska I, Peng Y, Tsakovska I, Alov P, Lagarde N, Jereva D, Villoutreix BO, Nicot AB, Pajeva I, Pencheva T, Miteva MA. Computational Analysis of Chemical Space of Natural Compounds Interacting with Sulfotransferases. Molecules (Basel, Switzerland). 26. PMID 34770768 DOI: 10.3390/molecules26216360 |
0.319 |
|
2021 |
Sellami A, Montes M, Lagarde N. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods. International Journal of Molecular Sciences. 22. PMID 33799614 DOI: 10.3390/ijms22062846 |
0.414 |
|
2020 |
Gyulkhandanyan A, Rezaie AR, Roumenina L, Lagarde N, Fremeaux-Bacchi V, Miteva MA, Villoutreix BO. Analysis of protein missense alterations by combining sequence- and structure-based methods. Molecular Genetics & Genomic Medicine. e1166. PMID 32096919 DOI: 10.1002/Mgg3.1166 |
0.343 |
|
2020 |
Ricco C, Abdmouleh F, Riccobono C, Guenineche L, Martin F, Goya-Jorge E, Lagarde N, Liagre B, Ali MB, Ferroud C, Arbi ME, Veitía MS. Pegylated triarylmethanes: Synthesis, antimicrobial activity, anti-proliferative behavior and in silico studies. Bioorganic Chemistry. 96: 103591. PMID 32004896 DOI: 10.1016/J.Bioorg.2020.103591 |
0.434 |
|
2019 |
Réau M, Lagarde N, Zagury JF, Montes M. Hits Discovery on the Androgen Receptor: In Silico Approaches to Identify Agonist Compounds. Cells. 8. PMID 31766271 DOI: 10.3390/Cells8111431 |
0.67 |
|
2019 |
Lagarde N, Goldwaser E, Pencheva T, Jereva D, Pajeva I, Rey J, Tuffery P, Villoutreix BO, Miteva MA. A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments. International Journal of Molecular Sciences. 20. PMID 31546814 DOI: 10.3390/Ijms20184648 |
0.45 |
|
2019 |
Dufies M, Grytsai O, Ronco C, Camara O, Ambrosetti D, Hagege A, Parola J, Mateo L, Ayrault M, Giuliano S, Grépin R, Lagarde N, Montes M, Auberger P, Demange L, et al. New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments. Theranostics. 9: 5332-5346. PMID 31410218 DOI: 10.7150/Thno.34681 |
0.341 |
|
2018 |
R Eacute Au M, Lagarde N, Zagury JF, Montes M. Nuclear Receptors DataBase Including Negative Data (NR-DBIND): A database dedicated to nuclear receptors binding data including negative data and pharmacological profile. Journal of Medicinal Chemistry. PMID 30354114 DOI: 10.1021/Acs.Jmedchem.8B01105 |
0.592 |
|
2018 |
Lagarde N, Rey J, Gyulkhandanyan A, Tufféry P, Miteva MA, Villoutreix BO. Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets. Oncotarget. 9: 32346-32361. PMID 30190791 DOI: 10.18632/Oncotarget.25966 |
0.48 |
|
2018 |
Réau M, Langenfeld F, Zagury JF, Lagarde N, Montes M. Decoys Selection in Benchmarking Datasets: Overview and Perspectives. Frontiers in Pharmacology. 9: 11. PMID 29416509 DOI: 10.3389/Fphar.2018.00011 |
0.663 |
|
2018 |
Rayar AM, Lagarde N, Martin F, Blanchard F, Liagre B, Ferroud C, Zagury JF, Montes M, Sylla-Iyarreta Veitía M. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling. European Journal of Medicinal Chemistry. 146: 577-587. PMID 29407982 DOI: 10.1016/J.Ejmech.2018.01.054 |
0.648 |
|
2017 |
Rayar AM, Lagarde N, Ferroud C, Zagury JF, Montes M, Veitía MS. Update on COX-2 selective inhibitors: chemical classification, side effects and their use in cancers and neuronal diseases. Current Topics in Medicinal Chemistry. PMID 28828990 DOI: 10.2174/1568026617666170821124947 |
0.636 |
|
2017 |
Lagarde N, Delahaye S, Jérémie A, Ben Nasr N, Guillemain H, Empereur-Mot C, Laville V, Labib T, Réau M, Langenfeld F, Zagury JF, Montes M. Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches. Molecular Informatics. PMID 28671755 DOI: 10.1002/Minf.201700020 |
0.701 |
|
2016 |
Lagarde N, Delahaye S, Zagury JF, Montes M. Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores. Journal of Cheminformatics. 8: 43. PMID 27602059 DOI: 10.1186/S13321-016-0154-2 |
0.705 |
|
2015 |
Lagarde N, Zagury JF, Montes M. Benchmarking Data Sets for the Evaluation of Virtual Ligand Screening Methods: Review and Perspectives Journal of Chemical Information and Modeling. 55: 1297-1307. PMID 26038804 DOI: 10.1021/Acs.Jcim.5B00090 |
0.642 |
|
2014 |
Lagarde N, Zagury JF, Montes M. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands. Journal of Chemical Information and Modeling. 54: 2915-44. PMID 25250508 DOI: 10.1021/Ci500305C |
0.703 |
|
2014 |
Lagarde N, Ben Nasr N, Jérémie A, Guillemain H, Laville V, Labib T, Zagury JF, Montes M. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database. Journal of Medicinal Chemistry. 57: 3117-25. PMID 24666037 DOI: 10.1021/Jm500132P |
0.708 |
|
2013 |
Ben Nasr N, Guillemain H, Lagarde N, Zagury JF, Montes M. Multiple structures for virtual ligand screening: defining binding site properties-based criteria to optimize the selection of the query. Journal of Chemical Information and Modeling. 53: 293-311. PMID 23312043 DOI: 10.1021/Ci3004557 |
0.732 |
|
Show low-probability matches. |